Donald Trump’s Medicare Executive Order Explained

President Donald Trump has rescinded former President Joe Biden‘s executive order 14087, which was put in place to lower the cost of prescription drugs for Americans. Newsweek has reached out to the Trump transition team outside of regular working hours via email for comment. Why It Matters Trump signed a flurry of executive orders and took a number of other ...

Read More

How Donald Trump’s Return Affects Hospitals: Medicaid, The Affordable Care Act And Tariffs

Hospitals are pressing Trump to preserve key funding for Medicare and other important priorities. But perhaps the biggest source of anxiety lies over the Medicaid program, which enables Americans with lower incomes to access healthcare.

Read More

Trump Rescinds Biden-Era Supplemental Health Benefits Notice Requirement

First-day administration moves also helped short-term health insurance and ended several Medicare efforts to change the way the drug market works.

Read More

Trump Names Acting Department Heads For DOL And HHS

Labor's temporary chief is Vince Micone, an official with extensive HR experience, and the temporary HHS chief is Dr. Dorothy Fink, a women's health specialist.

Read More

Simplifying ACA IRS Reporting: Employer Deadlines, Fire Relief, and New Compliance Updates

Applicable Large Employers (ALEs) in 2024 must file Affordable Care Act (ACA) reports with the IRS by March 31, 2025, detailing their compliance with the ACA’s employer mandate. ALEs must generate a report for each employee who worked full time for at least one full calendar month of 2024. Additionally, ALEs must furnish copies of these reports to ...

Read More

Trump Inherits Biden’s Unfinished Health Policies

The Trump administration inherited some big health policy headaches on Monday. And the nature of federal rules means it can’t start from scratch on key questions about surprise billing, coverage of GLP-1s and prescribing controlled substances. The big picture: All eyes will be on Trump health appointees as they sort through unfinished business from the Biden ...

Read More

Employers Grapple With Rising Health Care Costs And Fiduciary Concerns

Various pieces of health care transparency legislation have identified areas requiring employers to meet their fiduciary responsibilities, such as designing an evaluation process for selecting vendors to deploy their health and welfare benefits strategy.

Read More

Public Divided On Trump Health Agenda, Strong Support For Price Transparency

When asked about a variety of health care proposals, including those put forth by Republican and Democratic lawmakers, about 6 in 10 said boosting price transparency rules to ensure that health care prices are available to patients should be a top priority.

Read More

Medicare Targets 15 More Drugs For Price Negotiations — Including Ozempic

The Biden administration, in its last full weekday in office, announced the next 15 drugs up for Medicare price negotiation. Blockbuster diabetes drug Ozempic is on the list. That means the federal government and the pharmaceuticals industry are about to go head-to-head once again. The Centers for Medicare and Medicaid Services negotiated prices for a first ...

Read More

Top Three Insurers Reaped $7.3 Billion Through Their Drug Middlemen’s Markups, FTC Says

Regulators published their most detailed findings yet on how some of the nation’s largest companies profited from "excess" prescription price hikes of 1,000% or more.

Read More
arrowcaret-downclosefacebook-squarehamburgerinstagram-squarelinkedin-squarepauseplaytwitter-squareyoutube-square